Otsuka (OTCMKTS:OTSKY) Shares Up 10.6% – Here’s Why

Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY)’s stock price shot up 10.6% during trading on Tuesday . The stock traded as high as $38.20 and last traded at $38.05. 589 shares traded hands during mid-day trading, a decline of 99% from the average daily volume of 40,075 shares. The stock had previously closed at $34.4080.

Otsuka Price Performance

The firm has a market cap of $40.24 billion, a PE ratio of 15.05, a price-to-earnings-growth ratio of 7.76 and a beta of -0.04. The stock has a 50 day simple moving average of $34.21 and a two-hundred day simple moving average of $33.73. The company has a debt-to-equity ratio of 0.05, a quick ratio of 1.67 and a current ratio of 2.17.

Otsuka (OTCMKTS:OTSKY) last issued its earnings results on Friday, July 31st. The company reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.19. The firm had revenue of $4.41 billion for the quarter, compared to the consensus estimate of $3.95 billion. Otsuka had a return on equity of 12.93% and a net margin of 15.50%.Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. Sell-side analysts expect that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.12 earnings per share for the current year.

Otsuka Company Profile

Otsuka Pharmaceutical Co, Ltd., trading in the U.S. under the ticker OTCMKTS:OTSKY, is a global healthcare company headquartered in Tokyo, Japan. The firm’s core activities span the development, manufacturing and marketing of prescription pharmaceuticals, consumer healthcare products and nutraceuticals. Otsuka focuses its research on areas such as neuroscience, cardiovascular and renal therapies, and oncology, aiming to bring innovative treatments to patients worldwide.

Founded in 1964 by Busaburo Otsuka as a subsidiary of the Otsuka Group, the company has grown into a diversified healthcare enterprise over more than five decades.